PHAT
Phathom Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -4.4% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +3 | 31.41M | $340.87M | +8 | −5 |
| Q1 2026 | 70 | +3 | 28.31M | $314.61M | +9 | −6 |
| Q4 2025 | 67 | +2 | 22.91M | $380.11M | +2 | — |
| Q3 2025 | 13 | +2 | 15.27M | $179.73M | +2 | — |
| Q2 2025 | 8 | -4 | 10.36M | $99.34M | — | −4 |
| Q1 2025 | 9 | 0 | 3.37M | $21.12M | — | — |
| Q4 2024 | 9 | 0 | 2.95M | $23.99M | +2 | −2 |
| Q3 2024 | 8 | +2 | 2.05M | $37.04M | +3 | −1 |
| Q2 2024 | 6 | — | 1.55M | $15.95M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.04M | — | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.02M | +18.0% | $8.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.02M | +18.0% | $8.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 485.79K | +215.4% | $3.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 136.00K | -21.6% | $1.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 136.00K | -21.6% | $1.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 98.07K | Nuevo | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 98.07K | Nuevo | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 98.07K | Nuevo | $796,312 | 0.0% | New | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 72.01K | -67.3% | $584,697 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 59.99K | +82.2% | $487,127 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 25.64K | +21.8% | $209,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 17.66K | Nuevo | $143,383 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 17.66K | Nuevo | $143,383 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $796,312 | 0.0% |
| Marshall Wace | $796,312 | 0.0% |
| Marshall Wace | $796,312 | 0.0% |
| AQR Capital Management | $143,383 | 0.0% |
| AQR Capital Management | $143,383 | 0.0% |
Posición cerrada
| Point72 Asset Management | $7.95M | era 0.0% |
| D. E. Shaw & Co. | $2.60M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 173 tenedores, 68.60M acciones, $741.84M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.